Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Vaccines
|
April 23, 2025
<i>Bacillus Calmette-Guérin</i> Vaccination Promotes Efficient and Comprehensive Immune Modulation in Guinea Pig Models
In-Ohk Ouh, Min Jung Kim, Kwangwook Kim, et al.
Journal of Korean Medical Science
|
July 11, 2023
Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5 During the Seventh Domestic Outbreak in Korea in Early 2023
Jinyoung Yang, Seokhwan Hyeon, Jin Yang Baek, et al.
Frontiers in Immunology
|
March 20, 2023
Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections
Jinyoung Yang, Gunho Won, Jin Yang Baek, et al.
The Pediatric Infectious Disease Journal
|
January 31, 2025
Long-term Response to SARS-CoV-2 mRNA Vaccine in Adolescents
Mi Seon Han, Sujin Choi, Yoonsun Yoon, et al.
Immune Network
|
September 6, 2023
SARS-CoV-2 mRNA Vaccine Elicits Sustained T Cell Responses Against the Omicron Variant in Adolescents
Sujin Choi, Sang-Hoon Kim, Mi Seon Han, et al.
Frontiers in Cellular and Infection Microbiology
|
July 28, 2022
Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules
Ju-Yeon Choi, Young Jae Lee, Jae-Hoon Ko, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Vaccines
|
April 23, 2025
<i>Bacillus Calmette-Guérin</i> Vaccination Promotes Efficient and Comprehensive Immune Modulation in Guinea Pig Models
In-Ohk Ouh, Min Jung Kim, Kwangwook Kim, et al.
Journal of Korean Medical Science
|
July 11, 2023
Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5 During the Seventh Domestic Outbreak in Korea in Early 2023
Jinyoung Yang, Seokhwan Hyeon, Jin Yang Baek, et al.
Frontiers in Immunology
|
March 20, 2023
Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections
Jinyoung Yang, Gunho Won, Jin Yang Baek, et al.
The Pediatric Infectious Disease Journal
|
January 31, 2025
Long-term Response to SARS-CoV-2 mRNA Vaccine in Adolescents
Mi Seon Han, Sujin Choi, Yoonsun Yoon, et al.
Immune Network
|
September 6, 2023
SARS-CoV-2 mRNA Vaccine Elicits Sustained T Cell Responses Against the Omicron Variant in Adolescents
Sujin Choi, Sang-Hoon Kim, Mi Seon Han, et al.
Frontiers in Cellular and Infection Microbiology
|
July 28, 2022
Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules
Ju-Yeon Choi, Young Jae Lee, Jae-Hoon Ko, et al.
Page
of 5